FoxP3 was first reported in human pancreatic cancer cells, and later, it was also detected in breast cancer, prostate cancer, non-small cell lung cancer (NSCLC), gastric cancer, thyroid cancer, melanoma, and hepatocellular carcinoma [30,31,32,33]. Here, FOXP3 is linked to melanoma.